{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:16:29Z","timestamp":1790644589311,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Acute decompensated heart failure (HF) and cardiogenic shock (CS) frequently are refractory to conservative treatment and require mechanical circulatory support (MCS). We report our early clinical experience and evaluate patient outcomes with the newer generation surgical Impella 5.5.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seventy patients that underwent Impella 5.5 implantation between October 2019 and December 2021 at a single center were enrolled in this study. Pre-operative characteristics, peri-operative clinical course information, and post-operative outcomes were retrospectively collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-seven (81%) patients survived to discharge, and 51 (76%) patients survived at the time of the first 30\u2009days post-discharge visit. Thirty-one patients (44%) received Impella support for a bridge to advanced surgical heart failure therapy (transplant or durable left ventricular assist device [LVAD]), 27 (39%) cases were used for a bridge to recovery\/decision and 12 (17.1%) cases was used for planned perioperative support for high-risk cardiac surgery procedure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that Impella 5.5 provides favorable survival in the management of HF and CS, particularly used for a bridge to heart transplant or LVAD. Early extubation and mobilization with high flow circulatory support allowed effective tailoring of MCS approaches from peri-operative support for high-risk cardiac surgery, bridge to recovery, and to advanced surgical heart failure therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1018203","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T17:26:39Z","timestamp":1678123599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Single center experience and early outcomes of Impella 5.5"],"prefix":"10.3389","volume":"10","author":[{"given":"Masaki","family":"Funamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Kunavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahek","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMOA1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCOUTCOMES.115.002359","article-title":"Decade-Long trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction","volume":"9","author":"Goldberg","year":"","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"Van Diepen","year":"2017","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e000590","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e011991","DOI":"10.1161\/JAHA.119.011991","article-title":"Cardiogenic shock","volume":"8","author":"Vahdatpour","year":"","journal-title":"J Am Heart Assoc"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/EURHEARTJ\/EHT248","article-title":"Mechanical circulatory support in cardiogenic shock","volume":"35","author":"Werdan","year":"2014","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/J.IJCARD.2022.05.011","article-title":"Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: an updated meta-analysis","volume":"362","author":"Iannaccone","year":"2022","journal-title":"Int J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/J.AMJCARD.2016.11.037","article-title":"Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock","volume":"119","author":"Basir","year":"2017","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/J.JACC.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/J.JACC.2004.03.060","article-title":"Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry","volume":"44","author":"Fincke","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study","volume":"126","author":"O\u2019Neill","year":"2012","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/CCD.27427","article-title":"Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative","volume":"91","author":"Basir","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/MAT.0000000000001194","article-title":"New surgical circulatory support system outcomes","volume":"66","author":"Ramzy","year":"2020","journal-title":"ASAIO J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.ECHO.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"678748","DOI":"10.3389\/FCVM.2021.678748","article-title":"Complete revascularisation in Impella-supported infarct-related cardiogenic shock patients is associated with improved mortality","volume":"8","author":"Sch\u00e4fer","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/J.IJCARD.2015.10.063","article-title":"Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock. Lessons learned from the IMPRESS in STEMI trial","volume":"202","author":"Ouweneel","year":"2016","journal-title":"Int J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/J.JACC.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/15569845211013329","article-title":"Early outcomes of the first 200 US patients treated with Impella 5.5: a novel temporary left ventricular assist device","volume":"16","author":"Ramzy","year":"2021","journal-title":"Innovations (Phila)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/J.JACC.2022.01.018","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/CCD.29319","article-title":"Prospective validation of the SCAI shock classification: single center analysis","volume":"96","author":"Baran","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"E213","DOI":"10.1002\/CCD.28707","article-title":"Application of the SCAI classification in a cohort of patients with cardiogenic shock","volume":"96","author":"Schrage","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet (London, England)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e008527","DOI":"10.1161\/CIRCHEARTFAILURE.121.008527","article-title":"Intra-aortic balloon pumping in acute decompensated heart failure with Hypoperfusion: from pathophysiology to clinical practice","volume":"14","author":"Baldetti","year":"2021","journal-title":"Circ Heart Fail"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/J.CARDFAIL.2021.11.009","article-title":"Intra-aortic balloon pump for acute-on-chronic heart failure complicated by cardiogenic shock","volume":"28","author":"Morici","year":"2022","journal-title":"J Card Fail"},{"key":"ref25","unstructured":"KhanTM\n            SiddiquiAH\n          2022"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1056\/NEJM197305102881901","article-title":"Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial","volume":"288","author":"Scheidt","year":"1973","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/JOCS.14295","article-title":"Concomitant temporary mechanical support in high-risk coronary artery bypass surgery","volume":"34","author":"Ranganath","year":"2019","journal-title":"J Card Surg"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.37532\/FMIC.2020.12(2).650","article-title":"Impella-supported cardiac surgery","volume":"12","author":"Masiello","year":"2020","journal-title":"Interv Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"ivac088","DOI":"10.1093\/ICVTS\/IVAC088","article-title":"Impella support as a bridge to heart surgery in patients with cardiogenic shock","volume":"35","author":"Saito","year":"2022","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/J.JTCVS.2019.06.039","article-title":"Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation","volume":"159","author":"Biancari","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1253\/CIRCJ.CJ-14-1052","article-title":"Clinical assessment of hypoperfusion in acute heart failure \u2013 evergreen or antique?","volume":"79","author":"Frea","year":"2015","journal-title":"Circ J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"154024","DOI":"10.1016\/J.JCRC.2022.154024","article-title":"Prognostic implications of pulmonary artery catheter monitoring in patients with cardiogenic shock: a systematic review and meta-analysis of observational studies","volume":"69","author":"Bertaina","year":"2022","journal-title":"J Crit Care"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/CC11820","article-title":"Clinical review: early patient mobilization in the ICU","volume":"17","author":"Hodgson","year":"2013","journal-title":"Crit Care"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e14748","DOI":"10.1111\/CTR.14748","article-title":"Functional status of heart transplant recipients predicts survival","volume":"36","author":"Shaw","year":"2022","journal-title":"Clin Transpl"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/AJT.16977","article-title":"OPTN\/SRTR 2020 annual data report: heart","volume":"22","author":"Colvin","year":"2022","journal-title":"Am J Transplant"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1018203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T17:26:41Z","timestamp":1678123601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1018203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2023.1018203"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1018203","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"article-number":"1018203"}}